Home › Compare › LBPSW vs FCPT

LBPSW vs FCPT: Dividend Comparison 2026

LBPSW yields 4524.89% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LBPSW wins by $23623753001554.88M in total portfolio value
10 years
LBPSW
LBPSW
● Live price
4524.89%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23623753001554.93M
Annual income
$22,639,521,428,291,240,000.00
Full LBPSW calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — LBPSW vs FCPT

📍 LBPSW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLBPSWFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LBPSW + FCPT cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
LBPSW pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LBPSW
Annual income on $10K today (after 15% tax)
$384,615.38/yr
After 10yr DRIP, annual income (after tax)
$19,243,593,214,047,550,000.00/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, LBPSW beats the other by $19,243,593,214,047,547,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LBPSW + FCPT for your $10,000?

LBPSW: 50%FCPT: 50%
100% FCPT50/50100% LBPSW
Portfolio after 10yr
$11811876500777.49M
Annual income
$11,319,760,714,145,622,000.00/yr
Blended yield
95.83%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

LBPSW
No analyst data
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LBPSW buys
0
FCPT buys
0
No recent congressional trades found for LBPSW or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLBPSWFCPT
Forward yield4524.89% ✓6.05%
Annual dividend / share$2.00 ✓$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$23623753001554.93M ✓$49.1K
Annual income after 10y$22,639,521,428,291,240,000.00 ✓$5,775.28
Total dividends collected$23556931526764.89M ✓$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: LBPSW vs FCPT ($10,000, DRIP)

YearLBPSW PortfolioLBPSW Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$463,189$452,488.69$11,401$700.92+$451.8K → LBPSW
2$20,083,242$19,587,630.05$13,064$864.84+$20.07M → LBPSW
3$815,221,255$793,732,185.72$15,051$1,072.48+$815.21M → LBPSW
4$30,983,751,871$30,111,465,128.10$17,442$1,337.22+$30983.73M → LBPSW
5$1,102,716,232,298$1,069,563,617,796.09$20,340$1,677.08+$1102716.21M → LBPSW
6$36,755,536,844,597$35,575,630,476,038.90$23,880$2,116.57+$36755536.82M → LBPSW
7$1,147,553,137,482,484$1,108,224,713,058,765.00$28,241$2,689.36+$1147553137.45M → LBPSW
8$33,564,461,955,118,450$32,336,580,098,012,190.00$33,660$3,442.07+$33564461955.08M → LBPSW
9$919,842,591,835,224,700$883,928,617,543,247,700.00$40,456$4,439.95+$919842591835.18M → LBPSW
10$23,623,753,001,554,930,000$22,639,521,428,291,240,000.00$49,063$5,775.28+$23623753001554.88M → LBPSW

LBPSW vs FCPT: Complete Analysis 2026

LBPSW — Stock

4D pharma plc, together with its subsidiaries, engages in the research, development, and production of live biotherapeutic products. The company's development programs include Blautix for irritable bowel syndrome and Thetanix for paediatric crohn's disease. It also develops immuno-oncology products comprising MRx0518, MRx0573, and MRx1299 for solid tumors, and MRx0518 for pancreatic cancer; respiratory products, such as MRx-4DP0004 for asthma and COVID-19; central nervous system products, including MRx0005 and MRx0029 for neurodegeneration; and platform products comprising vaccines and autoimmune. 4D pharma plc has a collaboration agreement with Merck & Co., Inc. to conduct a clinical trial evaluating the combination of Keytruda and MRx0518 in patients with solid tumours. The company was formerly known as Schosween 18 Limited. 4D pharma plc was founded in 2014 and is headquartered in Leeds, the United Kingdom.

Full LBPSW Calculator →

FCPT — REIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this LBPSW vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LBPSW vs SCHDLBPSW vs JEPILBPSW vs OLBPSW vs KOLBPSW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.